Effects of Topical alo 2145 (P-Aminoclonidine Hydrochloride) on the Acute Intraocular Pressure Rise after Argon Laser Iridotomy

Alan L. Robin, Irvin P. Pollack, Joseph M. Defaller

Research output: Contribution to journalArticle

Abstract

A prospective, randomized, double-masked pilot study compared topical 1% ALO 2145 (p-aminoclonidine hydrochloride, a topical α2-agonist) with a placebo to determine its ability to minimize any acute postoperative intraocular pressure (IOP) increase after argon laser iridotomy. Twenty-eight eyes (21 patients) with chronic narrow angle glaucoma underwent argon laser iridotomy. Fourteen eyes were treated with ALO 2145; the remainder received a placebo. All eyes received one drop of the appropriate medication one hour before and following the iridotomy. Six eyes (43%) treated with the placebo and no eyes treated with ALO 2145 experienced an IOP increase greater than 10 mm Hg over baseline. The mean IOPs and mean IOP changes from baseline were significantly lower during the first three postoperative hours in the eyes treated with ALO 2145. No significant difference was noted in the ease of iridotomy formation, rate of iridotomy closure, visual acuity, anterior segment inflammation, or mean heart rate.

Original languageEnglish (US)
Pages (from-to)1208-1211
Number of pages4
JournalArchives of Ophthalmology
Volume105
Issue number9
DOIs
StatePublished - 1987

Fingerprint

Argon
Intraocular Pressure
Lasers
Placebos
Angle Closure Glaucoma
Aptitude
Double-Blind Method
Visual Acuity
Heart Rate
apraclonidine
Inflammation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Effects of Topical alo 2145 (P-Aminoclonidine Hydrochloride) on the Acute Intraocular Pressure Rise after Argon Laser Iridotomy. / Robin, Alan L.; Pollack, Irvin P.; Defaller, Joseph M.

In: Archives of Ophthalmology, Vol. 105, No. 9, 1987, p. 1208-1211.

Research output: Contribution to journalArticle

@article{6993073c67354b03965dd3fea0dde164,
title = "Effects of Topical alo 2145 (P-Aminoclonidine Hydrochloride) on the Acute Intraocular Pressure Rise after Argon Laser Iridotomy",
abstract = "A prospective, randomized, double-masked pilot study compared topical 1{\%} ALO 2145 (p-aminoclonidine hydrochloride, a topical α2-agonist) with a placebo to determine its ability to minimize any acute postoperative intraocular pressure (IOP) increase after argon laser iridotomy. Twenty-eight eyes (21 patients) with chronic narrow angle glaucoma underwent argon laser iridotomy. Fourteen eyes were treated with ALO 2145; the remainder received a placebo. All eyes received one drop of the appropriate medication one hour before and following the iridotomy. Six eyes (43{\%}) treated with the placebo and no eyes treated with ALO 2145 experienced an IOP increase greater than 10 mm Hg over baseline. The mean IOPs and mean IOP changes from baseline were significantly lower during the first three postoperative hours in the eyes treated with ALO 2145. No significant difference was noted in the ease of iridotomy formation, rate of iridotomy closure, visual acuity, anterior segment inflammation, or mean heart rate.",
author = "Robin, {Alan L.} and Pollack, {Irvin P.} and Defaller, {Joseph M.}",
year = "1987",
doi = "10.1001/archopht.1987.01060090066029",
language = "English (US)",
volume = "105",
pages = "1208--1211",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Effects of Topical alo 2145 (P-Aminoclonidine Hydrochloride) on the Acute Intraocular Pressure Rise after Argon Laser Iridotomy

AU - Robin, Alan L.

AU - Pollack, Irvin P.

AU - Defaller, Joseph M.

PY - 1987

Y1 - 1987

N2 - A prospective, randomized, double-masked pilot study compared topical 1% ALO 2145 (p-aminoclonidine hydrochloride, a topical α2-agonist) with a placebo to determine its ability to minimize any acute postoperative intraocular pressure (IOP) increase after argon laser iridotomy. Twenty-eight eyes (21 patients) with chronic narrow angle glaucoma underwent argon laser iridotomy. Fourteen eyes were treated with ALO 2145; the remainder received a placebo. All eyes received one drop of the appropriate medication one hour before and following the iridotomy. Six eyes (43%) treated with the placebo and no eyes treated with ALO 2145 experienced an IOP increase greater than 10 mm Hg over baseline. The mean IOPs and mean IOP changes from baseline were significantly lower during the first three postoperative hours in the eyes treated with ALO 2145. No significant difference was noted in the ease of iridotomy formation, rate of iridotomy closure, visual acuity, anterior segment inflammation, or mean heart rate.

AB - A prospective, randomized, double-masked pilot study compared topical 1% ALO 2145 (p-aminoclonidine hydrochloride, a topical α2-agonist) with a placebo to determine its ability to minimize any acute postoperative intraocular pressure (IOP) increase after argon laser iridotomy. Twenty-eight eyes (21 patients) with chronic narrow angle glaucoma underwent argon laser iridotomy. Fourteen eyes were treated with ALO 2145; the remainder received a placebo. All eyes received one drop of the appropriate medication one hour before and following the iridotomy. Six eyes (43%) treated with the placebo and no eyes treated with ALO 2145 experienced an IOP increase greater than 10 mm Hg over baseline. The mean IOPs and mean IOP changes from baseline were significantly lower during the first three postoperative hours in the eyes treated with ALO 2145. No significant difference was noted in the ease of iridotomy formation, rate of iridotomy closure, visual acuity, anterior segment inflammation, or mean heart rate.

UR - http://www.scopus.com/inward/record.url?scp=0023220944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023220944&partnerID=8YFLogxK

U2 - 10.1001/archopht.1987.01060090066029

DO - 10.1001/archopht.1987.01060090066029

M3 - Article

C2 - 3307717

AN - SCOPUS:0023220944

VL - 105

SP - 1208

EP - 1211

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 9

ER -